This may result in inhibition of STAT3 phosphorylation at Tyr705 followed by inhibition of STAT3 constitutive activation in colon tissues of CRC-mice (Fig. 4, 5), thereby inhibiting the transformation of colitis carcinoma in CRC-mice. The gene discussed is STAT3; the disease is colorectal carcinoma.